<p>(A) Representative images of hematoxylin and eosin (H & E) staining of mice fed the MCD diet for 1 week and 4 weeks or the control (CTR) diet. Scale bar, 100 μm. (B) Serum alanine aminotransferase (ALT) and triglyceride (TG) levels in MCD diet-fed mice over 8 weeks. <i>N</i> = 4–6, *<i>P</i> < 0.05 vs. MCD diet week 0, paired <i>t</i>-test. (C) Intrahepatic NK1.1<sup>+</sup> T (NKT) cells were evaluated by flow cytometry in MCD diet-fed mice over 6 weeks. <i>N</i> = 5–6, **<i>P</i> < 0.01, Student’s <i>t</i>-test. (D) Intrahepatic NKT cells, natural killer (NK) cells, and NK1.1<sup>-</sup> T (T) cells were measured by flow cytometry in MCD diet-fed mice for 1, 2, 4, 6, or 8 weeks. <i>N</i> = 2–6, *<i>P</i> < 0.05, vs. MCD 0 week, paired ...
Nonalcoholic steatohepatitis (NASH) arises from nonalcoholic fatty liver disease (NAFLD) as a conseq...
<p>Representative photomicrographs show the effects of the methionine- and choline deficient plus hi...
International audienceBACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially pro...
<div><p>Aim</p><p>Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. A met...
Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver d...
Hepatic inflammation is a key pathologic feature of nonalcoholic steatohepatitis (NASH). Natural kil...
<p>Wild type (Wt), myeloid IKKβ deficient (<i>IkbkbΔmye</i>), or hepatocyte IKKβ deficient (<i>Ikbkb...
Background Non-alcoholic steatohepatitis (NASH) is a common disease and feeding mice a methionine-ch...
Inflammatory digestive diseases, including non-alcoholic fatty liver disease (NAFLD), influence over...
<p>Mice were fed with a methionine-choline-sufficient (MCS) (A), methionine-choline-deficient (MCD) ...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...
Hepatic inflammation is a key pathologic feature of nonalcoholic steatohepatitis (NASH). Natural kil...
<p>C57Bl/6 mice were fed with methionine-choline deficient (MCD) or supplemented (MCS) control diet ...
Hepatic inflammation is a key pathologic feature of nonalcoholic steatohepatitis (NASH). Natural kil...
Nonalcoholic steatohepatitis (NASH) arises from nonalcoholic fatty liver disease (NAFLD) as a conseq...
Nonalcoholic steatohepatitis (NASH) arises from nonalcoholic fatty liver disease (NAFLD) as a conseq...
<p>Representative photomicrographs show the effects of the methionine- and choline deficient plus hi...
International audienceBACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially pro...
<div><p>Aim</p><p>Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. A met...
Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver d...
Hepatic inflammation is a key pathologic feature of nonalcoholic steatohepatitis (NASH). Natural kil...
<p>Wild type (Wt), myeloid IKKβ deficient (<i>IkbkbΔmye</i>), or hepatocyte IKKβ deficient (<i>Ikbkb...
Background Non-alcoholic steatohepatitis (NASH) is a common disease and feeding mice a methionine-ch...
Inflammatory digestive diseases, including non-alcoholic fatty liver disease (NAFLD), influence over...
<p>Mice were fed with a methionine-choline-sufficient (MCS) (A), methionine-choline-deficient (MCD) ...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...
Hepatic inflammation is a key pathologic feature of nonalcoholic steatohepatitis (NASH). Natural kil...
<p>C57Bl/6 mice were fed with methionine-choline deficient (MCD) or supplemented (MCS) control diet ...
Hepatic inflammation is a key pathologic feature of nonalcoholic steatohepatitis (NASH). Natural kil...
Nonalcoholic steatohepatitis (NASH) arises from nonalcoholic fatty liver disease (NAFLD) as a conseq...
Nonalcoholic steatohepatitis (NASH) arises from nonalcoholic fatty liver disease (NAFLD) as a conseq...
<p>Representative photomicrographs show the effects of the methionine- and choline deficient plus hi...
International audienceBACKGROUND AND AIMS: Non-alcoholic steatohepatitis (NASH), the potentially pro...